EUVIMEDOpdag EUVIMED
Crossref

Pharmacokinetic Determinants of Ponatinib‐Induced Vascular Toxicity: A Possible Role of Perivascular Adipose Tissue

Iwaine Benbouziane, Brygida Marczyk, Krzysztof Czamara iD, Zuzanna Kurylowicz, Elzbieta Buczek, Anna Gdula iD, Agnieszka Karas iD, Anna Bar, Agnieszka Kij, Stefan Chlopicki iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70181 ↗

At a glance

Journal article in Basic & Clinical Pharmacology & Toxicology, 2026. Written by Iwaine Benbouziane and 9 co-authors. Institution: Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland. Major MEDLINE topics: Imidazoles, Pyridazines, Adipose Tissue, Protein Kinase Inhibitors. 84 references. Funded by: European Regional Development Fund.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tyrosine kinase inhibitors (TKIs) have revolutionised chronic myeloid leukaemia treatment but cause cardiovascular toxicities through incompletely understood mechanisms. This study characterised the pharmacokinetics of imatinib, nilotinib and ponatinib, focusing on perivascular adipose tissue (PVAT) accumulation and vascular toxicity in C57BL/6 mice. Ponatinib showed unique pharmacokinetics with high apparent mean residence time (5.22 h vs. 1.51 h for imatinib, and 3.20 h for nilotinib) and high apparent distribution volume (2891.33 mL/kg vs. 683.75 mL/kg for imatinib, and 74.84 mL/kg for nilotinib). Importantly, ponatinib had exceptionally high tissue‐to‐plasma ratio in aorta with PVAT (8.44 vs. 0.37 for imatinib, and 0.14 for nilotinib). Chronic ponatinib treatment (10 mg/kg, 4 weeks) severely impaired endothelium‐dependent vasodilation assessed by magnetic resonance imaging in vivo (thoracic aorta −7.4 ± 1.1% vs. controls 5.1 ± 1.3%). Ponatinib accumulated in aorta with PVAT after chronic treatment and directly impaired adipocyte maturation in in vitro experiments. In isolated aorta, ponatinib reduced vascular nitric oxide (NO) release. In conclusion, endothelial dysfunction and impaired NO‐dependent function induced by ponatinib were related to a unique profile of ponatinib distribution compared with other TKIs, along with direct effects on adipocyte maturation. Our results suggest that after chronic treatment, ponatinib accumulation in PVAT leads to the impairment of the vasoprotective function of PVAT, contributing to endothelial dysfunction induced by ponatinib.

Subjects

MeSH terms (MEDLINE)

ImidazolesPyridazinesAdipose TissueProtein Kinase InhibitorsAnimalsMice, Inbred C57BLMalePyrimidinesMiceAorta, ThoracicImatinib MesylateNitric OxideVasodilationEndothelium, VascularAdipocytesTissue DistributionTyrosine Kinase InhibitorsMagnetic Resonance Imaging

Substances

ImidazolesponatinibPyridazinesProtein Kinase InhibitorsPyrimidinesnilotinibImatinib MesylateNitric OxideTyrosine Kinase Inhibitors

Authors and institutions

  • Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
  • Doctoral School of Exact and Natural Sciences, Jagiellonian University, Krakow, Poland.
  • Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland.

ORCID profiles: Krzysztof Czamara, Anna Gdula, Agnieszka Karas, Stefan Chlopicki

Funding

  • European Regional Development Fund

Cite

APA

Benbouziane, I., Marczyk, B., Czamara, K., Kurylowicz, Z., Buczek, E., Gdula, A., Karas, A., Bar, A., Kij, A., & Chlopicki, S. (2026). Pharmacokinetic Determinants of Ponatinib‐Induced Vascular Toxicity: A Possible Role of Perivascular Adipose Tissue. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70181

Vancouver

Benbouziane I, Marczyk B, Czamara K, Kurylowicz Z, Buczek E, Gdula A, et al. Pharmacokinetic Determinants of Ponatinib‐Induced Vascular Toxicity: A Possible Role of Perivascular Adipose Tissue. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70181

BibTeX
@article{Benbouziane2026,
  author = {Benbouziane, Iwaine and Marczyk, Brygida and Czamara, Krzysztof and Kurylowicz, Zuzanna and Buczek, Elzbieta and Gdula, Anna and Karas, Agnieszka and Bar, Anna and Kij, Agnieszka and Chlopicki, Stefan},
  title = {Pharmacokinetic Determinants of Ponatinib‐Induced Vascular Toxicity: A Possible Role of Perivascular Adipose Tissue},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70181}
}
Start for free →